Literature DB >> 12004680

A comprehensive review of oral cancer.

J Casiglia1, S B Woo.   

Abstract

Oral squamous cell carcinomas comprise 2-3% of all new malignancies diagnosed in the United States, making it the 10th most common malignancy. However, for the last few decades, the average five-year survival rate of 50% has not changed significantly. This article reviews the risk factors associated with the development of oral cancer and how premalignant (leukoplakia and erythroplakia) and actual cancerous lesions may appear. Diagnostic tools and aids to diagnosis are discussed, as are treatment modalities. It is imperative that all dental professionals perform a simple head and neck examination in addition to an oral examination during each new patient visit and each six-month recall appointment. Early detection saves lives.

Entities:  

Mesh:

Year:  2001        PMID: 12004680

Source DB:  PubMed          Journal:  Gen Dent        ISSN: 0363-6771


  39 in total

1.  Optical imaging predicts tumor response to anti-EGFR therapy.

Authors:  Emily E Helman; J Robert Newman; Nichole R Dean; Wenyue Zhang; Kurt R Zinn; Eben L Rosenthal
Journal:  Cancer Biol Ther       Date:  2010-07-15       Impact factor: 4.742

2.  Evidence for critical role of Tie2/Ang1 interaction in metastatic oral cancer.

Authors:  Daisuke Kitajima; Atsushi Kasamatsu; Dai Nakashima; Isao Miyamoto; Yasushi Kimura; Yosuke Endo-Sakamoto; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

3.  Gingival squamous cell carcinoma presenting as periodontal lesion in the mandibular posterior region.

Authors:  Renu Gupta; Nitai Debnath; Prathibha Anand Nayak; Vishal Khandelwal
Journal:  BMJ Case Rep       Date:  2014-08-19

4.  Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Lisa M Marubio; Arthur L Beaudet; David L Jolkovsky; Kent E Pinkerton; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma.

Authors:  K M Sathyan; R Sailasree; R Jayasurya; K Lakshminarayanan; Thomas Abraham; K R Nalinakumari; Elizabeth K Abraham; S Kannan
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-10       Impact factor: 4.553

6.  Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation.

Authors:  Hyunki Kim; Yolanda E Hartman; Guihua Zhai; Thomas K Chung; Melissa L Korb; Timothy M Beasley; Tong Zhou; Eben L Rosenthal
Journal:  J Magn Reson Imaging       Date:  2015-02-20       Impact factor: 4.813

7.  Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer.

Authors:  Hyun Min Jung; Brittany L Phillips; Rushi S Patel; Donald M Cohen; Andrew Jakymiw; William W Kong; Jin Q Cheng; Edward K L Chan
Journal:  J Biol Chem       Date:  2012-07-02       Impact factor: 5.157

8.  Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.

Authors:  Nichole R Dean; J Robert Newman; Emily E Helman; Wenyue Zhang; Seena Safavy; D M Weeks; Mark Cunningham; Linda A Snyder; Yi Tang; Li Yan; Lacey R McNally; Donald J Buchsbaum; Eben L Rosenthal
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

Review 9.  Oral cancer treatment.

Authors:  Terry A Day; Betsy K Davis; M Boyd Gillespie; John K Joe; Megan Kibbey; Bonnie Martin-Harris; Brad Neville; Mary S Richardson; Steven Rosenzweig; Anand K Sharma; Michelle M Smith; Stacy Stewart; Robert K Stuart
Journal:  Curr Treat Options Oncol       Date:  2003-02

10.  Development and evaluation of a low-cost, portable, LED-based device for PDT treatment of early-stage oral cancer in resource-limited settings.

Authors:  Hui Liu; Liam Daly; Grant Rudd; Amjad P Khan; Srivalleesha Mallidi; Yiran Liu; Filip Cuckov; Tayyaba Hasan; Jonathan P Celli
Journal:  Lasers Surg Med       Date:  2018-08-31       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.